Albert Garcia-Romeu is one of the principal researchers in the renaissance of psychedelics studies. He is doing his research at Johns Hopkins and focuses on psilocybin and how it can help with treating addiction.
From his bio: “Albert Perez Garcia-Romeu Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine, where he studies the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. He received his doctorate in Psychology in 2012 from the Institute of Transpersonal Psychology, where he researched self-transcendence and meditation, and their role in mental health. His current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness, and their underlying neurobiological mechanisms.“
He is also the principal investigator in the large study (starting August 2020) on psilocybin use in naturalistic settings, which is part of the cooperation between Johns Hopkins and Unlimited Sciences.
- Cessation and reduction in alcohol consumption and misuse after psychedelic use (Garcia-Romeu et al., 2019)
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction (Johnson et al., 2014)
- Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction (Garcia-Romeu, Griffiths & Johnson, 2014)
In our database you will also find him as an author on many more papers.
He has done several talks:
- Albert Garcia Romeu, PhD — Psilocybin in the Treatment of Mood and Substance Use Disorders (Portland Psychedelic Society, December 2018)
- Albert Garcia Romeu: The Case for Weight-Adjusted Psilocybin Dosing (Psychedelic Science Summit, 2017)
- Psilocybin in the Treatment of Smoking Addiction – Albert Garcia-Romeu (Psychedelic Science Summit, 2013)
- Horizons 2013: ALBERT GARCIA-ROMEU, Ph.D. “Psilocybin in the Treatment of Smoking Addiction” (Horizons, 2013)